Barinthus Biotherapeutics (BRNS)

• Market cap: $27.8M
• 1 day: -3.96%
• 5 days: -5.42%
• 1 month: -4.17%
• 3 months: -42.29%
• 6 months: -22.91%
• Year to date: -45.08%
• 1 year: -38.65%
• 5 years: -95.17%
• 10 years: -95.17%
• Sector: Healthcare
• Industry: Biotechnology

About: Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Employees: 105